Efficacy analysis of serum ferritin, Hcy, CRP combined with fat ultrasound parameters in predicting metabolic dysfunction-associated steatotic liver disease

血清铁蛋白、同型半胱氨酸、C反应蛋白联合脂肪超声参数预测代谢功能障碍相关脂肪肝疾病的疗效分析

阅读:2

Abstract

OBJECTIVE: To investigate the efficacy of combined prediction of serum ferritin, Hcy, CRP, and fat ultrasound parameters in metabolic dysfunction-associated steatotic liver disease (MASLD). METHODS: One hundred and two MASLD patients admitted to our hospital from November, 2021 to November, 2023 were selected as the MASLD group, and 106 healthy subjects were selected as healthy group on the basis of the principle of 1:1, and the healthy group was not accompanied by any basic diseases. The differences in demographic data, medical records and biochemical indicators between the MASLD group and the healthy group were analyzed by single factor analysis. The suspected influencing factors of MASLD were screened by single factor analysis. Apply multivariate Logistic regression to examine the independent predictors of MASLD. Employ ROC curve to anticipate the effect of single and combined indicators. RESULTS: Single factor analysis revealed that the SF, Hcy, CRP, and CAP level in MASLD group were significantly higher than healthy control group (p < 0.05). Multivariate Logistic analysis displayed that SF, Hcy, CRP, and CAP were independent predictors of alcoholic fatty liver disease (p < 0.05). ROC curve displayed that the area under the curve of the joint prediction of SF, Hcy, CRP, and CAP was 0.941, which was significantly higher than the area of SF, Hcy, CRP, and CAP alone. CONCLUSION: The combined application of serum SF, Hcy, CRP, and CAP has a high predictive efficiency for MASLD, which can be employed as an important reference indicator for early clinical diagnosis and intervention.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。